O Taiwan 3/97 ≥ 6 PD50* EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI02AA04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010348
Compound index — O
381 substances begin with O. 1 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, O Taiwan 3/97 ≥ 6 PD50* – Opium, raw.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
O-304 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010349
O-CYMEN-5-OL US-DRUG Not yet graded
US: unapproved drug other
Class as recordedDecreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010350
O1 BFS ≥ 6 PD50* EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI02AA04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010351
OAT CA-NHPUS-DRUG Not yet graded
Oat Beta-glucan CA-NHPEU-CLAIM Not yet graded
EU claims 1 authorised / 0 refusedCA licensed ingredient
Market presence1 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Oat beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease” | Authorised | Art.14(1)(a) | EFSA opinion |
Etalyn identifierETA-C-010353
OAT Bran US-DRUG Not yet graded
US: unapproved homeopathic
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010354
Oat grain fibre EU-CLAIM Not yet graded
EU claims 1 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Oat grain fibre contributes to an increase in faecal bulk” | Authorised | Art.13(1) | EFSA opinion |
| “Helps with weight control. For long-lasting sense of satiety. Frees energy slowly” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010355
Oat hull fibre CA-NHP Not yet graded
CA licensed ingredient
Market presence46 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010356
Oat Oil CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010357
Oatmeal US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence241 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010358
Oats beta-glucan EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Kaera kiudaine beeta-glükaani tarbimine soodustab seedimist. Kaera kiudaine beeta-glükaani tarbimine aitab soodustada seedimist. Clarification provided Consuming beta-glucan promotes digestion, improves digestive function.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Kaera kiudaine beeta-glükaani tarbimine suurendab küllastustunnet ehk täiskõhutunnet.Kaera kiudaine beeta-glükaani tarbimine pikendab küllastustunde ehk täiskõhutunde säilimist. Clarification provided Consuming oats beta-glucan increases satiety. Consuming oats beta-glucan prolongs the feeling of satiety.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010359
obecabtagene autoleucel EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01XL
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010360
Obeticholic Acid EU-MEDUS-DRUG Not yet graded
obicetrapib hemicalcium EU-MED Not yet graded
EU medicine: Opinion
Class as recordedC10A; C10B
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010362
Obiltoxaximab US-DRUG Not yet graded
US: bla
Class as recordedAnthrax Protective Antigen-directed Antibody Interactions [MoA]; Anthrax Protective Antigen-directed Antibody [EPC]
Earliest US approval2016
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010363
Obinutuzumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedCD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]; L01FA03
Earliest US approval2013
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010364
oblimersen EU-MED Not yet graded
EU medicine: Refused
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010365
Obsidian CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010366
Ocean Mineral Concentrate CA-NHP Not yet graded
CA licensed ingredient
Market presence58 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010367
Ocean Spray Cranberry Products®, juice drinks and sweetened dried berries Craisins® EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Regular consumption of 2 servings per day of an Ocean Spray product each containing typically 80 mg cranberry proanthocyanidins helps reduce the risk of urinary tract infection in women by inhibiting the adhesion of certain bacteria in the urinary tract” | Non-authorised | Art.14(1)(a) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010368
Ocfentanil US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesN-(2-Fluorophenyl)-2-methoxy-N-(1-; phenethylpiperidin-4-yl)acetamide
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010369
Ocimum Americanum Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010370
Ocimum basilicum CA-NHP Not yet graded
CA licensed ingredient
Market presence118 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010371
Ocimum basilicum ex herba CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010372
Ocimum Basilicum Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010373
Ocimum canum CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010374
Ocimum gratissimum CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010375
Ocimum minimum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010376
Ocimum Tenuiflorum TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010379
Ocrelizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]; Endoglycosidase [EPC]
Earliest US approval2017
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010381
Ocrelizumab And Hyaluronidase-Ocsq US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010382
Octacosanol CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010384
Octadecanoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010386
Octadecanoic acid, 2,3-dihydroxypropyl ester CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010387
Octanoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence82 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010388
Octanoic acid zinc salt CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010390
Octanoic acid, calcium salt (2:1) CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010389
Octenidine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010391
Octinoxate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Allergens [CS]
Earliest US approval1992
Market presence1,735 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010392
Octisalate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Allergens [CS]
Market presence3,335 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010393
octocog alfa EU-MED Not yet graded
EU medicine: Authorised, Lapsed
Class as recordedB02BD02
Market presence5 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010394
Octocrylene US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Allergens [CS]
Earliest US approval2006
Market presence2,709 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010395
Octopamine US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010396
Octreotide EU-MEDUS-DRUG Not yet graded
Odesivimab US-DRUG Not yet graded
US: bla
Earliest US approval2020
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010398
Odesivimab-Ebgn US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010399
Odevixibat EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient for human prescription compounding
also: Odevixibat Sesquihydrate
Class as recordedA05AX; A05AX05; Ileal Bile Acid Transporter Inhibitor [EPC]; Ileal Bile Acid Transporter Inhibitors [MoA]
Earliest US approval2021
Market presence13 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010400
Odontella aurita EU-NOVEL Not yet graded
Authorised novel food
also: Diatoma aurita Lyngbye 1819, Candollella aurita (Lyngbye) Gaillon 1833, Biddulphia aurita (Lyngbye) Brébisson 1838, Denticella aurita (Lyngbye)Ehrenberg 1838
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010401
Oenanthe Aquatica Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010403
Oenanthe crocata CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010404
Oenanthe Crocata Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Anticholinergic [EPC]; Catecholamine [EPC]
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010405
Oenanthe Crocata Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010406
Oenanthe javanica CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010407
Oenococcus oeni CA-NHPEU-NOVEL Not yet graded
Oenothera biennis CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Not novel in supplementsEU claims 0 authorised / 1 refusedCA licensed ingredient
also: Brunyera biennis Bubani
Market presence816 Canadian licensed products
Parts in scopeSeeds and seeds oil
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps maintain supple and flexible joints” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-010409
Oenothera Biennis Flower US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAcidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010410
Oenothera Biennis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010411
Oenothera biennis-eveninig primrose-seeds oil EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “.Regulates cholesterol level” | Non-authorised | Art.13(1) | EFSA opinion |
| “Anti-inflammatory / Helpful in eczema, mastalgia.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Stimulates the catabolism of saturated lipids. / Contributes to body weight reducing. / Helpful in reducing the adipose level and prevents arteriosclerosis.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010412
Oenotherae oleum CA-NHPEU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific dataCA licensed ingredient
also: Evening primrose oil; Oenothera biennis L.; Oenothera lamarckiana L.
Class as recordedherbal: Skin disorders and minor wounds
Market presence13 Canadian licensed products
Etalyn identifierETA-C-010413
of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2) - like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013–like strain(B/Utah/9/2014, wild type) EU-MED Not yet graded
EU medicine: Expired
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010414
Ofatumumab EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bla
Class as recordedCD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]; L01XC10; L04AA52
Earliest US approval2009
Market presence3 US product listings · 1 FDA applications · 2 EU medicines
Etalyn identifierETA-C-010415
Ofloxacin US-DRUG Not yet graded
US: anda
Class as recordedQuinolone Antimicrobial [EPC]; Quinolones [CS]
Earliest US approval1990
Market presence92 US product listings · 34 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010416
Oglufanide US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010417
Oil from Ulkenia sp. EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010418
Oil of muscade CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010419
Oil of turpentine CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010420
Oils from Schizochytrium sp. and strains of Schizochytrium limacinum EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010421
Okoubaka CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010422
Okoubaka aubrevillei CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010423
Okoubaka Aubrevillei Bark US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence13 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010424
Olanzapine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedAtypical Antipsychotic [EPC]; N05AH03; Opioid Antagonist [EPC]; Opioid Antagonists [MoA]
Earliest US approval1996
Market presence290 US product listings · 57 FDA applications · 12 EU medicines
Etalyn identifierETA-C-010425
Olaparib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01XK01; Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
Earliest US approval2014
Market presence22 US product listings · 5 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010426
Olaparib Hemi-2-Propanol US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010427
Oldenlandia diffusa CA-NHP Not yet graded
CA licensed ingredient
Market presence82 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010429
Olea europaea CA-NHPEU-NOVEL Not yet graded
Olea Europaea Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence22 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010431
Olea Europaea Flower BUD US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010432
Olea Europaea Fruit Volatile Oil US-DRUG Not yet graded
US: unapproved homeopathic
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010433
Olea Europaea Leaf US-DRUG Not yet graded
US: unapproved homeopathic
also: Olea Europaea (olive) Leaf Powder
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Cell-mediated Immunity [PE]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010434
Olea Europaea Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence26 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010435
Olea Europaea Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010436
Olea europaea-flos CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010437
Olea europea CA-NHP Not yet graded
CA licensed ingredient
Market presence120 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010438
Oleae folium EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Olive leaf; Olea europaea L.
Class as recordedherbal: Urinary tract and genital disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-010439
Oleander CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010440
Oleic acid CA-NHPEU-CLAIM Not yet graded
EU claims 1 authorised / 0 refusedCA licensed ingredient
Market presence1 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Replacing saturated fats in the diet with unsaturated fats contributes to the maintenance of normal blood cholesterol levels. Oleic acid is an unsaturated fat.” | Authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-010441
Oleoresin of Capsicum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010442
Oleoylethanolamide (OEA) EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010443
Oleum animale CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010444
Oleum gaultheriae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010445
Oleum Menthae Dementholatum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010446
Oleum morrhuae CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010447
Oleum oenothera biennis (oil) CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010448
Oleum richi CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010449
Oleum ricini CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010450
Oleum terebinthinae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010451
Oleuropein US-DRUG Not yet graded
US: unapproved homeopathic
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010452
Olezarsen Sodium EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedAPOC-III-directed RNA Interaction [EPC]; Antisense Oligonucleotide [EPC]; Antisense [CS]; C10AX
Earliest US approval2024
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010453
Olibanum CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence1 US product listings · 7 Canadian licensed products
Etalyn identifierETA-C-010454
Oliceridine US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2020
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010455
Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl{time} )amine fumarate) US-CSA Not yet graded
CSA Schedule IInarcotic
also: Oliceridine methyl] -9- -6-oxaspiro [4.5]decan-9-yl]ethyl{time} )amine fumarate)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010456
Oligofructose-enriched inulin (specific selection of short & long chains) from chicory EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “-increased bone mineral density; -increased bone strength.” | Non-authorised | Art.13(1) | EFSA opinion |
| “increases/ promotes/ enhances Calcium absorption.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010457
Oligomères Procyanidoliques (OPC) de raisin EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Soutient les performances visuelles Renforce les fonctions visuelles Clarification provided Grapeseeds extract improve visual adaptation to low luminance /participate to the visual performance/protect cornea/supports visual function.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010458
Oligopeptide-10 US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010459
Olipudase Alfa-Rpcp US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010461
Olive CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010462
Olive (Olea europaea L.) leaf water extract EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Daily intake of supplemental olive leaf extract polyphenols contributes to the reduction of the blood glucose rise after meals.” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010463
Olive Oil CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 3 refusedCA licensed ingredientUS: bulk ingredient
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Earliest US approval2013
Market presence9 US product listings · 2 FDA applications · 5 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Olive Oil promotes your heart health” | Non-authorised | Art.13(1) | EFSA opinion |
| “Olive Oil promotes your heart health” | Non-authorised | Art.13(1) | EFSA opinion |
| “Olive Oil promotes your heart health” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-010464
Olive oil and/or olive pomace oil. EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Olive oil consumption helps to maintain the health of the cardiovascular system” | Non-authorised | Art.13(1) | EFSA opinion |
| “Olive oil consumption helps to maintain the health of the cardiovascular system” | Non-authorised | Art.13(1) | EFSA opinion |
| “Olive oil consumption helps to maintain the health of the cardiovascular system” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010465
Olive oil polyphenols EU-CLAIM Not yet graded
EU claims 1 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Olive oil polyphenols contribute to the protection of blood lipids from oxidative stress” | Authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010466
Olmesartan Medoxomil US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]
Earliest US approval2002
Market presence328 US product listings · 67 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010468
Olodaterol US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAdrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; beta2-Adrenergic Agonist [EPC]
Earliest US approval2014
Market presence5 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010469
Olopatadine Hydrochloride EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]
Earliest US approval1996
Market presence135 US product listings · 38 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010470
Olsalazine Sodium US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAminosalicylate [EPC]; Aminosalicylic Acids [CS]
Earliest US approval1990
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010471
Olutasidenib US-DRUG Not yet graded
US: nda
Earliest US approval2022
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010472
Omadacycline US-DRUG Not yet graded
US: bulk ingredient
Class as recordedTetracycline-class Antibacterial [EPC]; Tetracyclines [CS]
Earliest US approval2018
Market presence8 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010474
Omalizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAnti-IgE [EPC]; Decreased IgE Activity [PE]; IgE-directed Antibody Interactions [MoA]; R03DX05
Earliest US approval2003
Market presence11 US product listings · 1 FDA applications · 2 EU medicines
Etalyn identifierETA-C-010475
Omalizumab-Igec US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010476
Omaveloxolone EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; N07XX25
Earliest US approval2023
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010477
Omberacetam US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010478
Ombitasvir, Paritaprevir, Ritonavir US-DRUG Not yet graded
Earliest US approval2014
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010480
Omecamtiv Mecarbil US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010481
omecamtiv mecarbil dihydrochloride hydrate EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedC01CX10
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010482
Omega EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Omega 3 fatty acids support a healthy heart.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010483
omega 3 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “pourraient améliorer l'absorption intestinale du calcium” | Non-authorised | Art.13(1) | EFSA opinion |
| “pourrait améliorer la fixation du calcium sur l'os” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010484
Omega 3 fatty acids EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Omega 3 fatty acids help to maintain a healthy cardiovascular system” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010485
Omega 3 Long chain fatty acids EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps / contributes to / promotes / supports the body's defence; stimulates the immune system.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010486
Omega 3-Fatty acids containing eicosapentaenoic acid-EPA and docosahexaenoic acid (DHA) EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contributes to the good functioning of the immunity system. /” | Non-authorised | Art.13(1) | EFSA opinion |
| “Decreases lipid levels / Function in regulation of lipid metabolism / Reduces lipids and LDL-cholesterol levels” | Non-authorised | Art.13(1) | EFSA opinion |
| “Function in the synthesis of prostaglandins. Helps in inflammatory, rheumatismal disease.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010487
Omega 6 (Linolenic acid from olive oil) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Nutrient for the skin” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010488
Omega-3 acid ethyl ester CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010489
Omega-3 and Omega-6 fatty acids (GLA) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- Yes Richtiges Verhältnis von omega-3 und omega-6 Fettsäuren zugunsten der omega-3 Fettsäuren - 100-3000mg EPA+DHA per day” | Non-authorised | Art.13(1) | EFSA opinion |
| “Omega-3 fatty acids with GLA support women during menstruation, PMS and menopause” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010490
Omega-3 fatty acid-lysine salt EU-NOVEL Not yet graded
Not novel in food
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010491
OMEGA-3 Fatty Acids CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 2 refusedCA licensed ingredientUS: bulk ingredient
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence4 US product listings · 45 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Omega-3 fatty acids protect skin from UV damage and keep the skin healthy” | Non-authorised | Art.13(1) | EFSA opinion |
| “To protect the cardiovascular system/It promotes heart health To support the fat metabolism” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-010492
Omega-3 fatty acids (Hi-EPA) with Glucosamine EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Omega-3 fatty acids (Hi-EPA) with Glucosamine help to maintain joint health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010495
Omega-3 fatty acids, DHA/EPA, Marine oils such as fish oil, cod liver oil containing DHA and EPA EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps maintain mobility and flexibility of joints/helps diminish morning stiffness in joints/ helps maintain healthy, flexible, mobile and supple joints” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010494
Omega-3 fatty acids/alpha-linoleic acid EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Omega-3 fatty acids are needed for growth and development. Omega-3 fatty acids are needed as building material for cells. Omega-3 fatty acids have an effect on vision. Omega-3 fatty acids have an effect on skin condition. Omega-3 fatty acids have an effect on blood pressure and regulation of nervous system activity.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Omega-3 fatty acids have an effect on blood pressure and regulation of nervous system activity.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010493
Omega-3 fish body oil - PUFAs EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Involved in the immune system May help maintain a healthy immune system May help maintain healthy joints Joint care” | Non-authorised | Art.13(1) | EFSA opinion |
| “May help maintain a healthy digestive system Gentle on the stomach Appearance of skin, healthy looking skin, a part of your daily skin care routine, helps maintain a good complexion.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010496
Omega-3 marine triglycerides CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010497
Omega-3 stable fish body oil EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Natural stable omega-3 fatty acids help to maintain a healthy heart” | Non-authorised | Art.13(1) | EFSA opinion |
| “Natural stable omega-3 fatty acids help to maintain supple joints. Natural stable omega-3 fatty acids help manage anti-inflammatory responses.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010498
Omega-3-Acid Ethyl Esters US-DRUG Not yet graded
US: anda
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Calculi Dissolution Agent [EPC]; Copper Absorption Inhibitor [EPC]
Earliest US approval2004
Market presence38 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010499
Omega-3-Acid Ethyl Esters Type A US-DRUG Not yet graded
Earliest US approval2014
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010500
Omega-3-Carboxylic Acids US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2014
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010501
Omega-3acid Ethyl Esters US-DRUG Not yet graded
Earliest US approval2007
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010502
OMEGA-6 Fatty Acids US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010503
Omega-9 fatty acids CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010504
Omeprazole EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAlkalinizing Activity [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
Earliest US approval1989
Market presence456 US product listings · 64 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010505
Omidenepag Isopropyl US-DRUG Not yet graded
US: bulk ingredient
Class as recordedProstaglandin E2 Receptor Agonist [EPC]; Prostaglandin E2 Receptor Agonists [MoA]
Earliest US approval2022
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010506
Omphalia lapidescens CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010507
OnabotulinumtoxinA US-DRUG Not yet graded
Earliest US approval1991
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010508
Oncorhynchus gobuscha CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010510
Oncorhynchus gorbuscha CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010511
Oncorhynchus mykiss EU-NOVEL Not yet graded
Not novel in food
Parts in scopeHard tissue mass
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010512
Ondansetron US-DRUG Not yet graded
US: anda
Class as recordedSerotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
Earliest US approval1991
Market presence313 US product listings · 85 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010513
Ondansetron, (3R)- US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010514
one of the following inactivated bluetongue virus strains:Inactivated bluetongue virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010515
onfekafusp alfa EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedL01XY
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010516
Oniscus asellus CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010517
Ononidis radix EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Restharrow root; Ononis spinosa L.
Class as recordedherbal: Urinary tract and genital disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-010518
Ononis Campestris US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedDepigmenting Activity [PE]; Melanin Synthesis Inhibitor [EPC]; Melanin Synthesis Inhibitors [MoA]; Oxidation-Reduction Activity [MoA]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010519
Ononis Repens Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010520
Ononis Repens Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010521
Ononis spinosa CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010522
Ononis Spinosa Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010523
Onopordum acanthium CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010524
Onopordum Acanthium Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010525
Onosma bracteatum CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010526
Onosmodium Virginianum CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence18 US product listings · 26 Canadian licensed products
Etalyn identifierETA-C-010527
Onosmodium Virginianum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010528
Oophorinum CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010529
OPC Plus, containing 40 mg oligomeric procyanidins (OPC) and 40 mg berry-blend per capsule EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “OPC Plus has been shown to increase the microcirculation and may therefore reduce the risk of chronic venous insufficiency” | Non-authorised | Art.14(1)(a) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010530
OPC Premium, containing 40 mg oligomeric procyanidins (OPC) and 400 mg berry-blend per capsule EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “OPC have been shown to reduce blood cholesterol levels and may therefore reduce the risk of cardiovascular disease” | Non-authorised | Art.14(1)(a) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010531
Operculina turpethum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010532
Ophicalcite CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010533
Ophiocordyceps sinensis CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Cordyceps sinensis (Berk.) Sacc., Sphaeria sinensis Berk., Hirsutella hepiali C.T. Chen & N.Y. Shen
Market presence927 Canadian licensed products
Parts in scopeMycelium and fruiting body (sporophore)
Etalyn identifierETA-C-010534
Ophiopogon CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010535
Ophiopogon japonicus CA-NHP Not yet graded
CA licensed ingredient
Market presence769 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010536
Ophiopogon Japonicus Whole US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010537
Opicapone EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, LapsedUS: bulk ingredient
Class as recordedCatechol O-Methyltransferase Inhibitors [MoA]; Catechol-O-Methyltransferase Inhibitor [EPC]; N04; N04;N04BX04
Earliest US approval2020
Market presence8 US product listings · 1 FDA applications · 2 EU medicines
Etalyn identifierETA-C-010538
Opipramol Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010539
Opium US-DRUG Not yet graded
US: bulk ingredient
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010540
Opium combination product 25 mg/du US-CSA Not yet graded
CSA Schedule IIInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesParegoric, other combination products
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010541
Opium extracts US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010542
Opium fluid extract US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010543
Opium poppy Opium preparations - 100 mg/(100 ml or 100 gm) V Y Parepectolin; Kapectolin PG; Kaolin Pectin P.G. US-CSA Not yet graded
CSA Schedule IInarcotic
also: Opium poppy Opium preparations - 100 mg/ V Y Parepectolin; Kapectolin PG; Kaolin Pectin P.G.
Class as recordedDEA: narcotic / opioid
DEA other namesPapaver somniferum
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010545
Opium tincture US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesLaudanum
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010548
Opium, granulated US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesGranulated opium
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010544
Opium, powdered US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesPowdered opium
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010546
Opium, raw US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesRaw opium; gum opium
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010547